HOME › DRUGS › CRISABOROLE
ACTIVE SUBSTANCE / INN

CRISABOROLE

Brand name(s): CRISABOROLE, EUCRISA, Staquis
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
NONE (TENTATIVE APPROVAL)
NDA207695
ANDA216242
ACTIVE SUBSTANCE
Crisaborole
REGULATORS
FDA · EMA
SPONSORS / MAH
MACLEODS PHARMS LTD, Pfizer Europe MA EEIG, ANACOR PHARMS INC
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EUCRISANDA207695ANACOR PHARMS INCPrescription
CRISABOROLEANDA216242MACLEODS PHARMS LTDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
StaquisPfizer Europe MA EEIGWithdrawn27/03/2020Dermatitis, Atopic

FULL INTELLIGENCE ON CRISABOROLE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →